These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20546266)

  • 21. A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level.
    Guo Z; L'italien GJ; Jing Y; Baker RA; Forbes RA; Hebden T; Kim E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1326-32. PubMed ID: 21515328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Luis Bautista J; Bugos C; Dirnberger G; Atherton T
    Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug titration patterns and HbA 1c levels in type 2 diabetes.
    Maclean JR; Chapman RH; Ferrufino CP; Krishnarajah G
    Int J Clin Pract; 2009 Jul; 63(7):1008-16. PubMed ID: 19570118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.
    DeFronzo RA; Stonehouse AH; Han J; Wintle ME
    Diabet Med; 2010 Mar; 27(3):309-17. PubMed ID: 20536494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' impatience is an independent determinant of poor diabetes control.
    Reach G; Michault A; Bihan H; Paulino C; Cohen R; Le Clésiau H
    Diabetes Metab; 2011 Dec; 37(6):497-504. PubMed ID: 21550831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial.
    Snoek FJ; van der Ven NC; Twisk JW; Hogenelst MH; Tromp-Wever AM; van der Ploeg HM; Heine RJ
    Diabet Med; 2008 Nov; 25(11):1337-42. PubMed ID: 19046225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels.
    Chepulis L; Mayo C; Morison B; Keenan R; Lao C; Paul R; Lawrenson R
    J Prim Health Care; 2020 Dec; 12(4):318-326. PubMed ID: 33349319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between depression and concurrent Type 2 diabetes outcomes varies by diabetes regimen.
    Aikens JE; Perkins DW; Piette JD; Lipton B
    Diabet Med; 2008 Nov; 25(11):1324-9. PubMed ID: 19046223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diabetes mellitus medication choice decision aid: a randomized trial.
    Mullan RJ; Montori VM; Shah ND; Christianson TJ; Bryant SC; Guyatt GH; Perestelo-Perez LI; Stroebel RJ; Yawn BP; Yapuncich V; Breslin MA; Pencille L; Smith SA
    Arch Intern Med; 2009 Sep; 169(17):1560-8. PubMed ID: 19786674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes.
    Egede LE; Gebregziabher M; Hunt KJ; Axon RN; Echols C; Gilbert GE; Mauldin PD
    Diabetes Care; 2011 Apr; 34(4):938-43. PubMed ID: 21335370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAP study: RCT of a medication adherence program for patients with type 2 diabetes.
    Odegard PS; Christensen DB
    J Am Pharm Assoc (2003); 2012; 52(6):753-62. PubMed ID: 23229961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging the Gap Between Self-Reported and Claims-Derived Adherence Measures for Basal Insulin Among Patients with Type 2 Diabetes Mellitus.
    Stephenson JJ; Bae JP; Raval AD; Kern DM
    Adv Ther; 2019 Jan; 36(1):118-130. PubMed ID: 30536142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
    Mattoo V; Eckland D; Widel M; Duran S; Fajardo C; Strand J; Knight D; Grossman L; Oakley D; Tan M;
    Clin Ther; 2005 May; 27(5):554-67. PubMed ID: 15978304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.